Susan Shenoi1,2, Jing-Ni Ou3, Chester Ni4, Claudia Macaubas5, Vivian H Gersuk4, Carol A Wallace1,2, Elizabeth D Mellins5, Anne M Stevens2,3. 1. Center for Clinical and Translational Research, Seattle Children's Research Institute, Seattle, Washington. 2. Division of Rheumatology, Department of Pediatrics, University of Washington, Seattle, Washington. 3. Center for Immunity and Immunotherapies, Seattle Children's Research Institute, Seattle, Washington. 4. Genomics Core, Systems Immunology, Benaroya Research Institute at Virginia Mason, Seattle, Washington. 5. Division of Human Gene Therapy, Program in Immunology, Stanford University, Stanford, California.
Abstract
BACKGROUND: Differentiation of systemic juvenile idiopathic arthritis (SJIA) fever from other childhood fevers is often delayed due to the lack of reliable, specific biomarkers. We hypothesized that PD-L1 expression is dysregulated in SJIA monocytes and compared it to other candidate SJIA biomarkers. METHODS: This pilot study enrolled children with fever without source and compared PD-L1 expression on myeloid cells to C-reactive protein, erythrocyte sedimentation rate, leukocyte counts, S100A12, S100A8, S100A9, calprotectin, and procalcitonin. Logistic regression models were fit to test SJIA diagnosis with each marker used as an independent predictor. Receiver operating characteristic curves and area under curve were calculated. Gene expression profiling on a subset of samples was performed. RESULTS: Twenty subjects (10 active SJIA, 10 febrile non-SJIA) were enrolled. S100 proteins were significantly elevated in SJIA with >80% sensitivity and >90% specificity. PD-L1 expression was significantly lower in SJIA. Other markers were not specific for SJIA. On exploratory gene analysis, 106 genes were significant for SJIA association, and several of these are associated with immune response pathways. CONCLUSION: In this small cohort, S100 proteins were specific diagnostic biomarkers for SJIA in children with fever. Decreased PD-L1 surface expression on circulating myeloid cells in SJIA suggests possible mechanism for loss of peripheral immune regulation.
BACKGROUND: Differentiation of systemic juvenile idiopathic arthritis (SJIA) fever from other childhood fevers is often delayed due to the lack of reliable, specific biomarkers. We hypothesized that PD-L1 expression is dysregulated in SJIA monocytes and compared it to other candidate SJIA biomarkers. METHODS: This pilot study enrolled children with fever without source and compared PD-L1 expression on myeloid cells to C-reactive protein, erythrocyte sedimentation rate, leukocyte counts, S100A12, S100A8, S100A9, calprotectin, and procalcitonin. Logistic regression models were fit to test SJIA diagnosis with each marker used as an independent predictor. Receiver operating characteristic curves and area under curve were calculated. Gene expression profiling on a subset of samples was performed. RESULTS: Twenty subjects (10 active SJIA, 10 febrile non-SJIA) were enrolled. S100 proteins were significantly elevated in SJIA with >80% sensitivity and >90% specificity. PD-L1 expression was significantly lower in SJIA. Other markers were not specific for SJIA. On exploratory gene analysis, 106 genes were significant for SJIA association, and several of these are associated with immune response pathways. CONCLUSION: In this small cohort, S100 proteins were specific diagnostic biomarkers for SJIA in children with fever. Decreased PD-L1 surface expression on circulating myeloid cells in SJIA suggests possible mechanism for loss of peripheral immune regulation.
Authors: Dirk Holzinger; Michael Frosch; Astrid Kastrup; Femke H M Prince; Marieke H Otten; Lisette W A Van Suijlekom-Smit; Rebecca ten Cate; Esther P A H Hoppenreijs; Sandra Hansmann; Halima Moncrieffe; Simona Ursu; Lucy R Wedderburn; Johannes Roth; Dirk Foell; Helmut Wittkowski Journal: Ann Rheum Dis Date: 2012-01-20 Impact factor: 19.103
Authors: Olcay Y Jones; Charles H Spencer; Suzanne L Bowyer; Peter B Dent; Beth S Gottlieb; C Egla Rabinovich Journal: Pediatrics Date: 2006-05 Impact factor: 7.124
Authors: Jane W Newburger; Masato Takahashi; Michael A Gerber; Michael H Gewitz; Lloyd Y Tani; Jane C Burns; Stanford T Shulman; Ann F Bolger; Patricia Ferrieri; Robert S Baltimore; Walter R Wilson; Larry M Baddour; Matthew E Levison; Thomas J Pallasch; Donald A Falace; Kathryn A Taubert Journal: Pediatrics Date: 2004-12 Impact factor: 7.124
Authors: Haidong Dong; Scott E Strome; Eric L Matteson; Kevin G Moder; Dallas B Flies; Gefeng Zhu; Hideto Tamura; Colin L W Driscoll; Lieping Chen Journal: J Clin Invest Date: 2003-02 Impact factor: 14.808
Authors: Shima Yasin; Ndate Fall; Rachel A Brown; Maggie Henderlight; Scott W Canna; Charlotte Girard-Guyonvarc'h; Cem Gabay; Alexei A Grom; Grant S Schulert Journal: Rheumatology (Oxford) Date: 2020-02-01 Impact factor: 7.580
Authors: Edwin J W Geven; Martijn H J van den Bosch; Irene Di Ceglie; Giuliana Ascone; Shahla Abdollahi-Roodsaz; Annet W Sloetjes; Sven Hermann; Michael Schäfers; Fons A J van de Loo; Peter M van der Kraan; Marije I Koenders; Dirk Foell; Johannes Roth; Thomas Vogl; Peter L E M van Lent Journal: Arthritis Res Ther Date: 2016-10-24 Impact factor: 5.156